- Home
- ARTL vs SGLY Comparison
ARTL vs SGLY Comparison
Compare ARTL & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTL
- SGLY
- Stock Information
- Founded
- ARTL 2011
- SGLY 2001
- Country
- ARTL United States
- SGLY United States
- Employees
- ARTL N/A
- SGLY N/A
- Industry
- ARTL Biotechnology: Pharmaceutical Preparations
- SGLY
- Sector
- ARTL Health Care
- SGLY
- Exchange
- ARTL Nasdaq
- SGLY Nasdaq
- Market Cap
- ARTL 3.3M
- SGLY 3.0M
- IPO Year
- ARTL N/A
- SGLY 2008
- Fundamental
- Price
- ARTL $1.02
- SGLY $1.19
- Analyst Decision
- ARTL
- SGLY
- Analyst Count
- ARTL 0
- SGLY 0
- Target Price
- ARTL N/A
- SGLY N/A
- AVG Volume (30 Days)
- ARTL 1.2M
- SGLY 98.9K
- Earning Date
- ARTL 05-16-2025
- SGLY 05-26-2025
- Dividend Yield
- ARTL N/A
- SGLY N/A
- EPS Growth
- ARTL N/A
- SGLY N/A
- EPS
- ARTL N/A
- SGLY N/A
- Revenue
- ARTL N/A
- SGLY $2,255,541.00
- Revenue This Year
- ARTL N/A
- SGLY N/A
- Revenue Next Year
- ARTL N/A
- SGLY N/A
- P/E Ratio
- ARTL N/A
- SGLY N/A
- Revenue Growth
- ARTL N/A
- SGLY N/A
- 52 Week Low
- ARTL $0.82
- SGLY $0.54
- 52 Week High
- ARTL $1.59
- SGLY $7.65
- Technical
- Relative Strength Index (RSI)
- ARTL 52.13
- SGLY 68.22
- Support Level
- ARTL $0.99
- SGLY $0.87
- Resistance Level
- ARTL $1.05
- SGLY $1.15
- Average True Range (ATR)
- ARTL 0.07
- SGLY 0.12
- MACD
- ARTL 0.00
- SGLY 0.05
- Stochastic Oscillator
- ARTL 30.00
- SGLY 98.31
About ARTL Artelo Biosciences Inc.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.